Mark A Sirgo
CIK 1301715 · President and CEO · last filed 2023-03-31
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$17.8K
Companies
4
Total Filings
130
Lifetime Open-Market Net
$255.3K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| 9 METERS BIOPHARMA, INC. (NMTR) Delisted | Director | 86,982 | $0.07 | $6.3K | $949.2K | 21 | 2023-03-31 |
| BMRA | Director | 8,700 | $2.05 | $17.8K | -$80.9K | 8 | 2021-12-10 |
| SALIX PHARMACEUTICALS LTD (SLXP) Delisted | Director | 37,427 | — | — | -$623.2K | 23 | 2014-08-26 |
| BIODELIVERY SCIENCES INTERNATIONAL INC (BDSIW) Delisted | President and CEO | 819,943 | — | — | $10.1K | 3 | 2007-06-18 |
Recent Filings · Page 9 of 13
130 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-08-19 | — | Buy (P) | +5,100 | $22.6K | |
| 2013-06-24 | — | Buy (P) | +3,400 | $14.6K | |
| 2013-05-31 | — | Grant (A) | +3,446 | $15.5K | |
| 2013-05-07 | SALIX PHARMACEUTICALS LTD (SLXP) Delisted | Sell (S) | −2,008 | -$108.4K | EDGAR |
| 2013-04-22 | SALIX PHARMACEUTICALS LTD (SLXP) Delisted | Grant (A) | +4,110 | $200.2K | EDGAR |
| 2013-03-22 | SALIX PHARMACEUTICALS LTD (SLXP) Delisted | Sell (S) | −3,000 | -$150.2K | EDGAR |
| 2013-01-15 | SALIX PHARMACEUTICALS LTD (SLXP) Delisted | Sell (S) | −3,000 | -$138.6K | EDGAR |
| 2012-12-21 | — | Buy (P) | +4,975 | $20.0K | |
| 2012-11-13 | SALIX PHARMACEUTICALS LTD (SLXP) Delisted | Sell (S) | −3,450 | -$139.8K | EDGAR |
| 2012-04-09 | SALIX PHARMACEUTICALS LTD (SLXP) Delisted | Grant (A) | +4,160 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.